MAPT and Alzheimer disease: Although there is frequent AD co‐pathology of amyloid and tau in individuals with PD, both in‐life52 and postmortem,53 and it is known that individuals with PD are at risk for developing AD‐type cognitive changes, our analyses revealed no discernible link between APOE genotypes and MoCA scores.